Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology. in Practice|November 28, 2025
Targeted Treatment in Asthma-Opportunities and ChallengesIoana Agache, Magdalena Zemelka-Wiacek, Radosław Gawlik, et al.Plos One|August 11, 2015
An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicumXin Long, Qian Chen, Jianping Zhao, et al.The Journal of Investigative Dermatology|December 11, 2012
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repairI-Hsin Kuo, Amanda Carpenter-Mendini, Takeshi Yoshida, et al.Plos One|January 18, 2024
Coordinating virus research: The Virus Infectious Disease OntologyJohn Beverley, Shane Babcock, Gustavo Carvalho, et al.The Journal of Allergy and Clinical Immunology|February 13, 2017
The role of ST2 and ST2 genetic variants in schistosomiasisXin Long, Michelle Daya, Jianping Zhao, et al.Scientific Reports|October 1, 2021
The effect of air pollution on the transcriptomics of the immune response to respiratory infectionDaniel P Croft, David S Burton, David J Nagel, et al.Family Medicine and Community Health|April 21, 2021
Rationales and uncertainties for aspirin use in COVID-19: a narrative reviewHazem A Sayed Ahmed, Eric Merrell, Mansoura Ismail, et al.Plos One|July 13, 2026
Triggering of viral and bacterial respiratory infection hospitalizations by traffic pollution exposure in a cohort of hospitalized adultsDaniel P Croft, Md Rayhanul Islam, Kelly Thevenet-Morrison, et al.The Journal of Allergy and Clinical Immunology|December 18, 2010
Tight junction defects in patients with atopic dermatitisAnna De Benedetto, Nicholas M Rafaels, Laura Y McGirt, et al.Health Science Reports|July 18, 2022
Effect of low dose acetylsalicylic acid and anticoagulant on clinical outcomes in COVID-19, analytical cross-sectional studyMuhammad B Malik, Samar A Amer, Eric Merrell, et al.Pageof 9